{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:16:07Z","timestamp":1781730967682,"version":"3.54.5"},"reference-count":20,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: In Vietnam, the Ministry of Health recently approved the use of Tdap vaccines\u2014Boostrix (2022) and Adacel (2024)\u2014for administration during pregnancy, aiming to provide passive antibody transfer to protect newborns against pertussis and tetanus from birth. However, uptake remains low, largely because Tdap is not included in the National Expanded Program on Immunization, vaccine hesitancy persists among obstetricians, and local safety data in pregnancy are limited. Methods: We conducted a prospective cohort study from September 2023 to September 2024 involving 485 pregnant women between 27 and 36 weeks of gestation at two major hospitals in Ho Chi Minh City: University Medical Center and Gia Dinh People\u2019s Hospital. Participants received either Tdap or monovalent tetanus toxoid vaccine (TT) as a comparator. Results: Among women in the Tdap group, 49.8% reported at least one adverse event following immunization (AEFI). Local reactions were the most frequent, primarily injection-site pain (43.8%). Fatigue (12.8%) was the most common systemic reaction, followed by headache (3.9%). Grade 3 AEFIs occurred in 5% of the Tdap group and included extensive local reactions (erythema or swelling &gt; 3 cm), high-grade fever (\u226540 \u00b0C), and severe fatigue interfering with daily activities or requiring hospitalization. Women receiving Tdap had 1.52-fold higher injection-site pain compared with those receiving TT (95% CI: 0.060\u20130.782). Importantly, co-administration of Tdap with inactivated quadrivalent influenza vaccine (IIV4) did not increase the risk of AEFIs. Furthermore, no evidence was found that Tdap vaccination adversely affected the course of pre-existing maternal comorbidities, which remained stable throughout pregnancy. Conclusions: This first large-scale Vietnamese cohort provides reassuring evidence on the safety of Tdap vaccination during pregnancy. These findings support broader implementation of maternal Tdap immunization, including concomitant administration with IIV4, to protect both mothers and infants.<\/jats:p>","DOI":"10.3390\/vaccines13101036","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:22:08Z","timestamp":1759911728000},"page":"1036","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety Evaluation of Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Tdap) During Pregnancy Among Vietnamese Women"],"prefix":"10.3390","volume":"13","author":[{"given":"Hien Minh","family":"Nguyen","sequence":"first","affiliation":[{"name":"Department of Physiology\u2013Pathophysiology\u2013Immunology, Medical School, University of Medicine and Pharmacy, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhat Thang","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Medical Center, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quoc Huy","family":"Pham","sequence":"additional","affiliation":[{"name":"Pasteur Institute, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5827-2274","authenticated-orcid":false,"given":"Huu Nghia","family":"Cao","sequence":"additional","affiliation":[{"name":"Pasteur Institute, Ho Chi Minh City 700000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2025, July 05). Pertussis\u2014Number of Reported Cases. Available online: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/pertussis-number-of-reported-cases."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Leontari, K., Lianou, A., Tsantes, A.G., Filippatos, F., Iliodromiti, Z., Boutsikou, T., Paliatsou, S., Chaldoupis, A.E., Ioannou, P., and Mpakosi, A. (2025). Pertussis in early infancy: Diagnostic challenges, disease burden, and public health implications amidst the 2024 resurgence, with emphasis on maternal vaccination strategies. Vaccines, 13.","DOI":"10.3390\/vaccines13030276"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100559","DOI":"10.1016\/j.ijregi.2024.100559","article-title":"Pertussis in southeast asia: Country-level burden and recommendations from the global pertussis initiative","volume":"14","author":"Nguyen","year":"2025","journal-title":"IJID Reg."},{"key":"ref_4","first-page":"10","article-title":"T\u1ed5ng quan ch\u1ea9n \u0111o\u00e1n v\u00e0 \u0111i\u1ec1u tr\u1ecb b\u1ec7nh ho g\u00e0","volume":"4","author":"Hai","year":"2021","journal-title":"Vietnam. J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Pham, N.T., Bui, Q.T., Tran, D.M., Larsson, M., Pham, M.P., and Olson, L. (2024). Pertussis seasonal variation in northern vietnam: The evidence from a tertiary hospital. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-17705-9"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in vietnam: Results of a randomized controlled trial pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1093\/cid\/ciw551","article-title":"The effect of maternal pertussis immunization on infant vaccine responses to a booster pertussis-containing vaccine in vietnam","volume":"63","author":"Maertens","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","first-page":"e2019280","article-title":"Adverse event occurrence following use of tetanus, diphtheria and acellular pertussis adsorbed vaccine-tdap-, s\u00e3o paulo, sp, brazil, 2015\u20132016. (Ocorr\u00eancia de eventos adversos ap\u00f3s o uso da vacina adsorvida difteria, t\u00e9tano e pertussis (acelular)-dTpa-, S\u00e3o Paulo, SP, 2015\u20132016)","volume":"29","author":"Luna","year":"2020","journal-title":"Epidemiol. Serv. Saude"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"A233","DOI":"10.1016\/j.vaccine.2014.12.017","article-title":"Thirty years of vaccination in vietnam: Impact and cost-effectiveness of the national expanded programme on immunization","volume":"33","author":"Jit","year":"2015","journal-title":"Vaccine"},{"key":"ref_10","unstructured":"Vo, V.T., Nguyen, T.-H., Vong, B.L., Pham, T.T.H., and Doan, N.H. (2024). Knowledge, attitude and practices related to tetanus-diphtheria-pertussis maternal vaccination in pregnant women at university medical center of ho chi minh city. 10th International Conference on the Development of Biomedical Engineering in Vietnam, Proceedings of the BME 2024, Phan Thiet, Vietnam, 25\u201327 July 2024, Springer."},{"key":"ref_11","unstructured":"B\u1ed9 Y t\u1ebf Vi\u1ec7t Nam (2025, July 17). Th\u00f4ng T\u01b0 Ban H\u00e0nh Danh M\u1ee5c b\u1ec7nh Truy\u1ec1n Nhi\u1ec5m, \u0110\u1ed1i T\u01b0\u1ee3ng v\u00e0 Ph\u1ea1m vi Ph\u1ea3i s\u1eed D\u1ee5ng v\u1eafc Xin, Sinh Ph\u1ea9m y T\u1ebf B\u1eaft Bu\u1ed9c. Available online: https:\/\/vbpl.vn\/TW\/Pages\/vbpq-toanvan.aspx?ItemID=169843."},{"key":"ref_12","first-page":"00077","article-title":"Barriers to tdap vaccination in pregnancy: Perspectives from obstetricians and patients","volume":"4","author":"Amin","year":"2018","journal-title":"Int. J. Pregnancy Child Birth"},{"key":"ref_13","first-page":"1","article-title":"Safety of the combination vaccination with tetanus-diphtheria-pertussis vaccine and vaccine against covid-19 in pregnant women at university medical centre ho chi minh city","volume":"2","author":"Nguyen","year":"2022","journal-title":"J. Control Vaccine Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1016\/j.vaccine.2020.10.070","article-title":"Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (ap, pertagen\u00ae) and tetanus, reduced-dose diphtheria combination (tdap, boostagen\u00ae) vaccine for immunization of adolescents and adults in thailand","volume":"38","author":"Fortuna","year":"2020","journal-title":"Vaccine"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chen, Q., Zhang, C., Ye, C., Zhu, J., Shen, J., Zhu, C., Yang, P., Liu, T., and Xu, Y. (2024). Surveillance for adverse events following immunization with dtap-containing combination vaccines in Linping, China, 2019\u20132022. Front. Public Health, 12.","DOI":"10.3389\/fpubh.2024.1278513"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.3346\/jkms.2019.34.e105","article-title":"A 6-year prospective, observational, multi-center post-marketing surveillance of the safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (tdap) vaccine in Korea","volume":"34","author":"Park","year":"2019","journal-title":"J. Korean Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e010911","DOI":"10.1136\/bmjopen-2015-009536","article-title":"Safety of tdap vaccine in pregnant women: An observational study","volume":"6","author":"Walls","year":"2016","journal-title":"BMJ Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"ref_19","unstructured":"WHO (2015). Pertussis Vaccines: Who Position Paper, August 2015. Wkly. Epidemiol. Rec., 90, 433\u2013460. Available online: https:\/\/www.who.int\/publications\/i\/item\/who-wer9035."},{"key":"ref_20","unstructured":"WHO (2022). Vaccines Against Influenza Who Position Paper, May 2022. Wkly. Epidemiol. Rec., 97, 185\u2013208. Available online: https:\/\/www.who.int\/publications\/i\/item\/who-wer9719."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/10\/1036\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:50:19Z","timestamp":1760035819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/10\/1036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["vaccines13101036"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13101036","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}